Skip to main content
. 2022 Jun 27;13(6):572. doi: 10.1038/s41419-022-05021-2

Fig. 7. A model depicts the role of the IDO1-MDM2-p53 pathway in DLBCL growth.

Fig. 7

MDM2 and p53 act downstream of IDO1 to regulate tumor cell growth. This illustrates that IDO1 inhibition could activate the p53 pathway and induce cell cycle arrest and apoptosis by downregulating MDM2 expression in DLBCL cells.